First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix’s Kidney Cancer Imaging Agent
Through this named patient program in the Netherlands (‘Leveren op Artsenverklaring’), physicians [...]
Strata Oncology Announces Presentations on Proprietary Multivariate Biomarkers at North America Conference on Lung Cancer and San Antonio Breast Cancer Symposium
Strata Oncology notes the data to be presented includes results [...]
Cold Spring Harbor Laboratory rolls out STEM ‘Bicycle Principles’
“We’ve all had horrible teachers,” recalls Jason Williams. Williams is [...]
Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries
Yourgene’s LightBench is an automated electrophoresis instrument, powered by Ranger® [...]
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Alloy Therapeutics and Wheeler Bio are offering a premium service [...]
Frontier Bio Leads Medical Innovation with “Lab-Grown” Blood Vessel Technology for Replacing Animal Testing
By introducing lab-grown vessels, Frontier Bio is championing a future [...]
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Be The Match BioTherapies®, an organization offering solutions for companies [...]
Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer
Associate Professor Eunah Kang and Mr. Youngjun Kim from the [...]
First Participant Treated at the Highest Dose Level in Clarity’s Theranostic Prostate Cancer Trial
Clarity’s Executive Chairperson, Dr Alan Taylor, commented, “Results from cohort 2 [...]
AI Therapeutics Announces Investigator Initiated Phase 2 Trial at UCSF to Study LAM-001 in Patients With Bronchiolitis Obliterans Syndrome (BOS) Post-Lung Transplant
LAM-001 is a proprietary, investigational, inhaled formulation of sirolimus, also [...]